Fu-Ying Dai1,2, Jun-Fang Wang1, Xue-Li Gong1, Lang Bao1. 1. a Laboratory of Infection and Immunity, West China Center of Medical Science , Sichuan University , Chengdu , China. 2. b Department of Pathogenic Biology , School of Basic Medical Science, Chengdu Medical College , Chengdu , China.
Abstract
OBJECTIVE: This study aimed to evaluate the immunogenicity and protective efficacy of recombinant bacille calmette-guerin (rBCG) strains expressing Ag85A (A), CFP10 (C), ESAT6 (E), IL-12p70 (I), and fusion protein GM-CSF (G). METHOD: rBCGs were established by integrating of A, C, E, I, G, AE, CE, IE, GC, GE and GCE into Mycobacterium bovis BCG-1173 and BCG-SH. The macro-effects of rBCGs on mice were evaluated by phenotype and weight. The immunogenicity of rBCGs was analyzed by lgG, lgG1 and lgG2a antibody titers, and IFN-γ and IL-4 contents through Enzyme-linked immunosorbent assay (ELISA). Meanwhile, the proportions of CD4+ and CD8+ T splenic lymphocytes were determined using flow cytometry. The protective efficacy of rBCGs was evaluated by bacterial load in spleen and lung tissues from immunized mice. RESULTS: rBCGs exhibited no obvious side effects on mice. The antibody titers of lgG, lgG1 and lgG2a, proportion of CD4+ and CD8+ T cells, and concentrations of IFN-γ were found to be significantly higher in multiple-gene rBCGs than that in single-gene rBCGs (P < 0.05). Bacterial load in both spleen and lung tissues from mice infected with M. tuberculosis H37Rv were significantly reduced by rBCGs. A significantly lower bacterial load was revealed in rBCG-1173:A compared with multiple-gene rBCGs (P < 0.05). CONCLUSION: Immunogenicity was better on multiple-gene rBCGs than on single-gene rBCGs, while excellent protective efficacy was exhibited on rBCG-1173:A and BCG-1173.
OBJECTIVE: This study aimed to evaluate the immunogenicity and protective efficacy of recombinant bacille calmette-guerin (rBCG) strains expressing Ag85A (A), CFP10 (C), ESAT6 (E), IL-12p70 (I), and fusion protein GM-CSF (G). METHOD: rBCGs were established by integrating of A, C, E, I, G, AE, CE, IE, GC, GE and GCE into Mycobacterium bovis BCG-1173 and BCG-SH. The macro-effects of rBCGs on mice were evaluated by phenotype and weight. The immunogenicity of rBCGs was analyzed by lgG, lgG1 and lgG2a antibody titers, and IFN-γ and IL-4 contents through Enzyme-linked immunosorbent assay (ELISA). Meanwhile, the proportions of CD4+ and CD8+ T splenic lymphocytes were determined using flow cytometry. The protective efficacy of rBCGs was evaluated by bacterial load in spleen and lung tissues from immunized mice. RESULTS: rBCGs exhibited no obvious side effects on mice. The antibody titers of lgG, lgG1 and lgG2a, proportion of CD4+ and CD8+ T cells, and concentrations of IFN-γ were found to be significantly higher in multiple-gene rBCGs than that in single-gene rBCGs (P < 0.05). Bacterial load in both spleen and lung tissues from mice infected with M. tuberculosis H37Rv were significantly reduced by rBCGs. A significantly lower bacterial load was revealed in rBCG-1173:A compared with multiple-gene rBCGs (P < 0.05). CONCLUSION: Immunogenicity was better on multiple-gene rBCGs than on single-gene rBCGs, while excellent protective efficacy was exhibited on rBCG-1173:A and BCG-1173.
Authors: Giovanni Battista Migliori; Rosella Centis; Chris Lange; Morgan D'Arcy Richardson; Giovanni Sotgiu Journal: Curr Opin Pulm Med Date: 2010-05 Impact factor: 3.155
Authors: Bappaditya Dey; Ruchi Jain; Aparna Khera; Vivek Rao; Neeraj Dhar; Umesh D Gupta; V M Katoch; V D Ramanathan; Anil K Tyagi Journal: Vaccine Date: 2009-10-15 Impact factor: 3.641
Authors: Asimenia Angelidou; Maria-Giulia Conti; Joann Diray-Arce; Christine S Benn; Frank Shann; Mihai G Netea; Mark Liu; Lakshmi Prasad Potluri; Guzman Sanchez-Schmitz; Robert Husson; Al Ozonoff; Beate Kampmann; Simon Daniël van Haren; Ofer Levy Journal: Vaccine Date: 2020-01-28 Impact factor: 4.169
Authors: Deepa Paliwal; Michelle Thom; Areej Hussein; Divyashree Ravishankar; Alex Wilkes; Bryan Charleston; Ian M Jones Journal: Front Mol Biosci Date: 2022-08-11